Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
RAPT Therapeutics logo — The Science to Overcome Inflammation and Cancer

RAPT Therapeutics

The Science to Overcome Inflammation and Cancer

Founded 2015 United States South San Francisco, United States 149 employees Venture round Total: $23.62M Advertising, Enterprise Software

General Information

Company Name RAPT Therapeutics
Founded Year 2015
Location United States South San Francisco, United States
Employees 149
Industries Advertising, Enterprise Software
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with RAPT Therapeutics. To contact RAPT Therapeutics, visit rapt.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RAPT Therapeutics compare?

A PDF of RAPT Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RAPT Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RAPT Therapeutics

RAPT Therapeutics is a clinical stage immunology-based therapeutics company founded in 2015 and headquartered in the United States. The company's slogan, "The Science to Overcome Inflammation and Cancer," resonates with its focus on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology. RAPT utilizes its proprietary discovery and development engine to create highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. The company has advanced two unique drug candidates, RPT193 and FLX475, each targeting C-C motif chemokine receptor 4 (CCR4) for the treatment of inflammation and cancer, respectively. Additionally, RAPT is actively pursuing a range of targets that are in the discovery stage of development. Notably, RAPT Therapeutics recently secured a significant $70.50 million Post-IPO Equity investment on 17 November 2022. Though the specific investors were not disclosed, this injection of capital underscores the confidence in RAPT's innovative approach and potential for addressing unmet medical needs in the fields of inflammation and oncology. With its compelling pipeline and focused mission, RAPT Therapeutics stands at the forefront of advancing immunology-based therapeutic solutions.

Business keywords: Immunology, Therapeutics, Small molecule therapies, Inflammatory diseases, Oncology, Drug discovery, Development engine, Small molecule drugs, C-C motif chemokine receptor 4 (CCR4), Inflammation treatment, Cancer treatment, Clinical stage company, Biopharmaceuticals, Immune modulation, Drug candidates

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
500 Startups
500 Startups
03 Nov 2013
Venture Round $3.39M 1
Levensohn Venture Partners
Levensohn Venture Partners
01 Nov 2007
Series D $11.23M 2
Summit Partners Levensohn Venture Partners
Summit Partners, Levensohn Venture Partners
24 Jan 2006
Series C $9.00M 3
Summit Partners Octane Capital Management Levensohn Venture Partners
Summit Partners, Octane Capital Management +1
30 Jul 2002

FAQ About RAPT Therapeutics

The Science to Overcome Inflammation and Cancer
RAPT Therapeutics was founded in 2015.
RAPT Therapeutics is headquartered in South San Francisco, United States.
RAPT Therapeutics operates in Advertising and Enterprise Software. Its work centres on Immunology, Therapeutics, Small molecule therapies and Inflammatory diseases.
RAPT Therapeutics has approximately 149 employees.
RAPT Therapeutics has completed 4 funding rounds, raising a total of $23.62M. The latest funding stage is Venture round.

We're actively collecting intelligence on RAPT Therapeutics.

Source: BounceWatch company record for RAPT Therapeutics, https://bouncewatch.com/company/rapt-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout